Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 2, 2021 23:09 UTC | Exercise / conversionPerformance Share Units · Derivative | 69,009.7798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016420 · doc4.xml · derivative · entry 5 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 69,009.7798 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2016 PBRSUs") granted to the Reporting Person. The 2016 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest 100% on February 26, 2021, which is the fifth anniversary of the grant date. F1 · price: On February 26, 2021, 69,009.7798 of the Reporting Person's performance based restricted share units vested. Read SEC document |
|
| February 26, 2021 Filed Mar 2, 2021 23:09 UTC | SaleCommon Shares | 27,115.1927 | $60.31 | $1,635,317.27 |
DisclosureSEC source: 0001209191-21-016420 · doc4.xml · nonDerivative · entry 2 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,491.8683 F2 · price: Represents shares sold to cover withholding tax obligations on the settlement of the reported vesting of the Reporting Person's performance based restricted share units. Read SEC document |
|
| February 26, 2021 Filed Mar 2, 2021 23:09 UTC | Exercise / conversionCommon Shares | 69,009.7798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016420 · doc4.xml · nonDerivative · entry 1 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,607.061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 26, 2021, 69,009.7798 of the Reporting Person's performance based restricted share units vested. Read SEC document |
|
| February 19, 2021 Filed Feb 23, 2021 18:53 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 33,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013434 · doc4.xml · derivative · entry 17 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Shares · 33,500 shares Expires 2024-02-19 F25 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:53 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 10,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013434 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,701 Underlying: Common Shares · 10,701 shares Expires not disclosed F7 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F23 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice president and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F24 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F24 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:53 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013434 · doc4.xml · derivative · entry 15 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires not disclosed F7 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F22 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F22 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:53 UTC |
Shear David ChanPresident, International
|
GrantCommon Shares | 3,210 | $60.55 | $194,365.50 |
DisclosureSEC source: 0001209191-21-013434 · doc4.xml · nonDerivative · entry 1 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,486.7558 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Machado FernandoChief Marketing Officer
|
GrantPerformance Share Units · Derivative | 33,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013436 · doc4.xml · derivative · entry 14 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Shares · 33,500 shares Expires 2024-02-19 F20 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Machado FernandoChief Marketing Officer
|
GrantRestricted Share Units · Derivative | 14,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013436 · doc4.xml · derivative · entry 13 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,011 Underlying: Common Shares · 14,011 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F19 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F19 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Machado FernandoChief Marketing Officer
|
GrantRestricted Share Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013436 · doc4.xml · derivative · entry 12 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F17 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023. F17 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Machado FernandoChief Marketing Officer
|
GrantCommon Shares | 4,203 | $60.55 | $254,491.65 |
DisclosureSEC source: 0001209191-21-013436 · doc4.xml · nonDerivative · entry 1 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,905.8702 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 18 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:56 UTC |
Finazzo Christopher L.See Remarks
|
GrantPerformance Share Units · Derivative | 20,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013437 · doc4.xml · derivative · entry 16 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Shares · 20,100 shares Expires 2024-02-19 F20 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:56 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 7,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013437 · doc4.xml · derivative · entry 15 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,148 Underlying: Common Shares · 7,148 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F19 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F19 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:56 UTC |
Finazzo Christopher L.See Remarks
|
GrantRestricted Share Units · Derivative | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013437 · doc4.xml · derivative · entry 14 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Shares · 9,900 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F17 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F17 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:56 UTC |
Finazzo Christopher L.See Remarks
|
GrantCommon Shares | 2,144 | $60.55 | $129,819.20 |
DisclosureSEC source: 0001209191-21-013437 · doc4.xml · nonDerivative · entry 1 Finazzo Christopher L. · CIK 0001801406 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,117.7619 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 18 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 100,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013420 · doc4.xml · derivative · entry 21 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,500 Underlying: Common Shares · 100,500 shares Expires 2024-02-19 F29 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 27,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013420 · doc4.xml · derivative · entry 20 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,864 Underlying: Common Shares · 27,864 shares Expires not disclosed F11 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F27 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F28 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F28 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 49,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013420 · doc4.xml · derivative · entry 19 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,500 Underlying: Common Shares · 49,500 shares Expires not disclosed F11 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F26 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F26 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Cil Jose E.Chief Executive Officer
|
GrantCommon Shares | 8,359 | $60.55 | $506,137.45 |
DisclosureSEC source: 0001209191-21-013420 · doc4.xml · nonDerivative · entry 1 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,156.2573 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 27 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 20,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013433 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Shares · 20,100 shares Expires 2024-02-19 F21 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 10,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013433 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,491 Underlying: Common Shares · 10,491 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F19 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2021 RSUs that have not yet vested. F20 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F20 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013433 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Shares · 9,900 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F18 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 4,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013431 · doc4.xml · derivative · entry 14 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,651 Underlying: Common Shares · 4,651 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F19 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 1.75 for vice presidents. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2021 RSUs that have not vested. F18 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F18 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013431 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 15,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F18 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
Friesner JacquelineSee Remarks
|
GrantCommon Shares | 1,594 | $60.55 | $96,516.70 |
DisclosureSEC source: 0001209191-21-013431 · doc4.xml · nonDerivative · entry 1 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,065.0878 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of her 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 19 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:51 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 83,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013429 · doc4.xml · derivative · entry 15 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,750 Underlying: Common Shares · 83,750 shares Expires 2024-02-19 F24 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:51 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 19,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013429 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,591 Underlying: Common Shares · 19,591 shares Expires not disclosed F20 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F22 · shares: The issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F23 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F23 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:51 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 41,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013429 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Shares · 41,250 shares Expires not disclosed F20 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F21 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F21 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:51 UTC |
Kobza JoshuaCOO
|
GrantCommon Shares | 5,877 | $60.55 | $355,852.35 |
DisclosureSEC source: 0001209191-21-013429 · doc4.xml · nonDerivative · entry 1 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,160.009 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 22 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sale price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:57 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 26,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013438 · doc4.xml · derivative · entry 14 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,800 Underlying: Common Shares · 26,800 shares Expires 2024-02-19 F18 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:57 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 7,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013438 · doc4.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,848 Underlying: Common Shares · 7,848 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F16 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F17 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F17 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:57 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013438 · doc4.xml · derivative · entry 12 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Shares · 13,200 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F15 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F15 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:57 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantCommon Shares | 2,372 | $60.55 | $143,624.60 |
DisclosureSEC source: 0001209191-21-013438 · doc4.xml · nonDerivative · entry 1 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,722.7587 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 16 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC | GrantPerformance Share Units · Derivative | 33,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013423 · doc4.xml · derivative · entry 16 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Shares · 33,500 shares Expires 2024-02-19 F22 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
|
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC | GrantRestricted Share Units · Derivative | 9,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013423 · doc4.xml · derivative · entry 15 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,966 Underlying: Common Shares · 9,966 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F20 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUs") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F21 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F21 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
|
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC | GrantRestricted Share Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013423 · doc4.xml · derivative · entry 14 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F19 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F19 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
|
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC | GrantCommon Shares | 2,990 | $60.55 | $181,044.50 |
DisclosureSEC source: 0001209191-21-013423 · doc4.xml · nonDerivative · entry 1 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,597.2812 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 20 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
|
| February 19, 2021 Filed Feb 23, 2021 23:45 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantPerformance Share Units · Derivative | 26,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013418 · doc4.xml · derivative · entry 13 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,800 Underlying: Common Shares · 26,800 shares Expires 2024-02-19 F21 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:45 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 10,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013418 · doc4.xml · derivative · entry 12 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,273 Underlying: Common Shares · 10,273 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F19 · shares: The Issuer granted the 2021 restricted share units ("2021 RSUS") to the Reporting Person pursuant to the Issuer's 2020 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2020 net bonus to purchase Investment Shares and received a matching grant of 2021 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $60.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2021 RSUs that have not yet vested. F20 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F20 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:45 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013418 · doc4.xml · derivative · entry 11 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Shares · 13,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023. F18 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:45 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantCommon Shares | 3,081 | $60.55 | $186,554.55 |
DisclosureSEC source: 0001209191-21-013418 · doc4.xml · nonDerivative · entry 1 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,864.1645 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2020 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2020 net bonus to purchase common shares at a purchase price of $60.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 19 below pursuant to the Issuer's 2020 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 18, 2021. Read SEC document |
| February 18, 2021 Filed Jan 4, 2022 18:11 UTC |
Behring AlexandreDirector
|
GiftCommon Shares | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001119 · doc4.xml · nonDerivative · entry 2 Behring Alexandre · CIK 0001421706 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 269,038 F1 · kind: The Reporting Person gifted these securities to ABH Investments Holdings Limited. The Reporting Person holds all voting and dispositive power for these securities. The Reporting Person disclaims beneficial ownership of the securities held by ABH Investments Holdings Limited except to the extent of his pecuniary interest therein. F2 · ownership.nature: These securities are held by ABH Investments Holdings Limited, of which the Reporting Person is the director and sole equity owner. The Reporting Person disclaims beneficial ownership of the securities held by ABH Investments Holdings Limited except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Jan 4, 2022 18:11 UTC |
Behring AlexandreDirector
|
GiftCommon Shares | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001119 · doc4.xml · nonDerivative · entry 1 Behring Alexandre · CIK 0001421706 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The Reporting Person gifted these securities to ABH Investments Holdings Limited. The Reporting Person holds all voting and dispositive power for these securities. The Reporting Person disclaims beneficial ownership of the securities held by ABH Investments Holdings Limited except to the extent of his pecuniary interest therein. Read SEC document |
| February 03, 2021 Filed Jan 4, 2022 22:58 UTC |
FRIBOURG PAUL JDirector
|
GiftCommon Shares | 24,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001077 · doc4.xml · nonDerivative · entry 4 FRIBOURG PAUL J · CIK 0001070938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,862 F5 · ownership.nature: Represents an indirect interest held by the Paul J. Fribourg 2017 Family Trust of which the Reporting Person is a trustee and his lineal descendants are the beneficiaries. Read SEC document |
| February 03, 2021 Filed Jan 4, 2022 22:58 UTC |
FRIBOURG PAUL JDirector
|
GiftCommon Shares | 24,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001077 · doc4.xml · nonDerivative · entry 3 FRIBOURG PAUL J · CIK 0001070938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 0 F2 · balance_after: Reflects the transfer of 90,000 shares previously held by the Reporting Person's prior 2020 grantor retained annuity trust to the Reporting Person and the transfer of 90,000 shares from the Reporting Person to the Reporting Person's new 2021 grantor retained annuity trust, in exempt transactions. F4 · ownership.nature: Represents an indirect interest held by the Reporting Person's 2020 grantor retained annuity trust. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 23:43 UTC |
Machado FernandoChief Marketing Officer
|
GrantDividend Equivalent Rights · Derivative | 96.2833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002606 · doc4.xml · derivative · entry 18 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454.9482 Underlying: Common Shares · 96.2833 shares Expires not disclosed F5 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F18 · derivative.exercise_date: These dividend equivalent rights accrued on the 2020 restricted share unit award (the "2020 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020 RSUs to which they relate. F18 · derivative.expiration_date: These dividend equivalent rights accrued on the 2020 restricted share unit award (the "2020 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020 RSUs to which they relate. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 23:43 UTC |
Machado FernandoChief Marketing Officer
|
GrantDividend Equivalent Rights · Derivative | 52.7817 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002606 · doc4.xml · derivative · entry 16 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419.0582 Underlying: Common Shares · 52.7817 shares Expires not disclosed F5 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F16 · derivative.exercise_date: These dividend equivalent rights accrued on the 2019 restricted share unit award (the "2019 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 RSUs to which they relate. F16 · derivative.expiration_date: These dividend equivalent rights accrued on the 2019 restricted share unit award (the "2019 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 RSUs to which they relate. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 23:43 UTC |
Machado FernandoChief Marketing Officer
|
GrantDividend Equivalent Rights · Derivative | 1,750.6877 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002606 · doc4.xml · derivative · entry 14 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,699.4258 Underlying: Common Shares · 1,750.6877 shares Expires not disclosed F13 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share, subject to increase or decrease based on the results of the Issuer performance condition. F14 · derivative.exercise_date: These dividend equivalent rights accrued on the 2019 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 PBRSUs to which they relate. F14 · derivative.expiration_date: These dividend equivalent rights accrued on the 2019 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 PBRSUs to which they relate. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 23:43 UTC |
Machado FernandoChief Marketing Officer
|
GrantDividend Equivalent Rights · Derivative | 38.1538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002606 · doc4.xml · derivative · entry 12 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429.7602 Underlying: Common Shares · 38.1538 shares Expires not disclosed F5 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F11 · derivative.exercise_date: These dividend equivalent rights accrued on the 2018 restricted share unit award (the "2018 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2018 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2018 RSUs to which they relate. F11 · derivative.expiration_date: These dividend equivalent rights accrued on the 2018 restricted share unit award (the "2018 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2018 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2018 RSUs to which they relate. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 23:43 UTC |
Machado FernandoChief Marketing Officer
|
GrantDividend Equivalent Rights · Derivative | 48.6107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002606 · doc4.xml · derivative · entry 9 Machado Fernando · CIK 0001801288 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611.5092 Underlying: Common Shares · 48.6107 shares Expires not disclosed F5 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.